Published in Tissue Eng on November 01, 2007
Growth factors, matrices, and forces combine and control stem cells. Science (2009) 8.46
Functional skeletal muscle formation with a biologic scaffold. Biomaterials (2010) 1.55
Engineered contractile skeletal muscle tissue on a microgrooved methacrylated gelatin substrate. Tissue Eng Part A (2012) 1.03
Tissue engineering of functional skeletal muscle: challenges and recent advances. IEEE Eng Med Biol Mag (2008) 0.90
Effect of implantation on engineered skeletal muscle constructs. J Tissue Eng Regen Med (2012) 0.90
Engineered skeletal muscle units for repair of volumetric muscle loss in the tibialis anterior muscle of a rat. Tissue Eng Part A (2014) 0.89
Engineering skeletal muscle repair. Curr Opin Biotechnol (2013) 0.88
Electrical stimulation as a biomimicry tool for regulating muscle cell behavior. Organogenesis (2013) 0.85
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications. Tissue Eng Part B Rev (2014) 0.85
Functional recovery of completely denervated muscle: implications for innervation of tissue-engineered muscle. Tissue Eng Part A (2012) 0.85
Decellularized Human Skeletal Muscle as Biologic Scaffold for Reconstructive Surgery. Int J Mol Sci (2015) 0.83
Neuromuscular Junction Formation in Tissue-Engineered Skeletal Muscle Augments Contractile Function and Improves Cytoskeletal Organization. Tissue Eng Part A (2015) 0.81
Striated muscle function, regeneration, and repair. Cell Mol Life Sci (2016) 0.76
Synergizing Engineering and Biology to Treat and Model Skeletal Muscle Injury and Disease. Annu Rev Biomed Eng (2015) 0.76
Voluntary movement controlled by the surface EMG signal for tissue-engineered skeletal muscle on a gripping tool. Tissue Eng Part A (2013) 0.75
Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery. Drug Discov Today (2016) 0.75
Creating Interactions between Tissue-Engineered Skeletal Muscle and the Peripheral Nervous System. Cells Tissues Organs (2016) 0.75
Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach. Front Pharmacol (2017) 0.75
Tissue engineering and regenerative medicine research perspectives for pediatric surgery. Pediatr Surg Int (2010) 0.75
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA (2006) 5.95
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med (2010) 4.77
Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med (2012) 4.55
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med (2003) 3.85
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29
Vitamin B12 deficiency. Am Fam Physician (2003) 3.01
Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases. J Am Coll Cardiol (2005) 3.01
A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention. Am J Cardiol (2003) 2.72
Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology (2002) 2.07
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med (2006) 1.97
The V-Y advancement flap is equivalent to the Mustardé flap for ectropion prevention in the reconstruction of moderate-size lid-cheek junction defects. Plast Reconstr Surg (2013) 1.94
Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA (2005) 1.70
Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology (2003) 1.60
Use of Acellular Dermal Matrix in Postmastectomy Breast Reconstruction: Are All Acellular Dermal Matrices Created Equal? Plast Reconstr Surg (2015) 1.49
Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study. Circ Cardiovasc Qual Outcomes (2009) 1.48
Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med (2003) 1.44
Evidence-based reports--is there any evidence? Reg Anesth Pain Med (2003) 1.43
The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.42
Utility of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA registry. J Invasive Cardiol (2004) 1.40
New and simplified method for multiple left ventricle catheterizations in small animals. Interact Cardiovasc Thorac Surg (2008) 1.40
Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting. Catheter Cardiovasc Interv (2010) 1.39
Lack of Association between Blood Pressure Management by Anesthesia Residents and Competence Committee Evaluations or In-training Exam Performance: A Cohort Analysis. Anesthesiology (2016) 1.38
Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med (2008) 1.37
Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg (2013) 1.33
The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression. Antimicrob Agents Chemother (2010) 1.27
Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am J Cardiol (2007) 1.23
An implantable device for stimulation of denervated muscles in rats. Med Eng Phys (2003) 1.20
Comparison of gene expression of 2-mo denervated, 2-mo stimulated-denervated, and control rat skeletal muscles. Physiol Genomics (2005) 1.19
Microfeature guided skeletal muscle tissue engineering for highly organized 3-dimensional free-standing constructs. Biomaterials (2009) 1.18
Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery (2009) 1.18
Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg (2010) 1.16
Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med (2004) 1.13
Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng (2005) 1.13
Competency in electrocardiogram interpretation among internal medicine and emergency medicine residents. Am J Med (2005) 1.13
Early sustained ventricular arrhythmias complicating acute myocardial infarction. Am J Med (2008) 1.12
Are individual differences in fatigue vulnerability related to baseline differences in cortical activation? Behav Neurosci (2005) 1.11
The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med (2009) 1.09
Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol (2004) 1.05
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain. J Med Chem (2008) 1.04
Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases. Diabetes Care (2004) 1.03
Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol (2012) 1.02
Tissue engineering of recellularized small-diameter vascular grafts. Tissue Eng (2005) 1.01
Resident participation does not affect surgical outcomes, despite introduction of new techniques. J Am Coll Surg (2010) 0.98
High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg (2008) 0.95
In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.94
Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg (2006) 0.94
Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol Aging (2013) 0.93
Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model. Antimicrob Agents Chemother (2011) 0.92
Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesth Analg (2012) 0.89
Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention. Am Heart J (2006) 0.89
Gender-age interaction in early mortality following primary angioplasty for acute myocardial infarction. Am J Cardiol (2006) 0.89
Increased synaptic GluR1 subunits in the anterior cingulate cortex of rats with peripheral inflammation. Eur J Pharmacol (2010) 0.89
Tissue-engineered axially vascularized contractile skeletal muscle. Plast Reconstr Surg (2006) 0.89
Cardiovascular effects of ephedra alkaloids: a comprehensive review. Prog Cardiovasc Dis (2005) 0.89
Implantation increases tensile strength and collagen content of self-assembled tendon constructs. J Appl Physiol (1985) (2010) 0.88
Insulin-like growth factors and coronary heart disease. Cardiol Rev (2004) 0.88
Using an anesthesia information management system to improve case log data entry and resident workflow. Anesth Analg (2011) 0.88
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency. Neurobiol Aging (2012) 0.87
Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2010) 0.87
Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system. Antimicrob Agents Chemother (2011) 0.87
Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers. Drug Saf (2002) 0.86
Microelectrical sensors as emerging platforms for protein biomarker detection in point-of-care diagnostics. Expert Rev Mol Diagn (2009) 0.86
Examining the effect of a patient navigation intervention on outpatient cardiac rehabilitation awareness and enrollment. J Cardiopulm Rehabil Prev (2013) 0.85
A manual physical therapy approach versus subacromial corticosteroid injection for treatment of shoulder impingement syndrome: a protocol for a randomised clinical trial. BMJ Open (2011) 0.85
Modulation of microtubule dynamics by the microtubule-associated protein 1a. J Neurosci Res (2009) 0.85
A strategy to prevent substance abuse in an academic anesthesiology department. J Clin Anesth (2010) 0.84
Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention. Am Heart J (2011) 0.84
Design of potent inhibitors of human beta-secretase. Part 1. Bioorg Med Chem Lett (2006) 0.84
Getting to the heart of tissue engineering. J Cardiovasc Transl Res (2008) 0.84
Acute exertional compartment syndrome of the forearm. J Trauma (2008) 0.83
Poly(glycerol-dodecanoate), a biodegradable polyester for medical devices and tissue engineering scaffolds. Biomaterials (2009) 0.83
Silicon induces minimal thromboinflammatory response during 28-day intravascular implant testing. ASAIO J (2010) 0.83
Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease. Pharmacol Res (2011) 0.82
Catastrophic hemothorax from lobar pulmonary artery puncture during attempted subclavian vein catheterization: the fallibility of venous blood aspiration. J Clin Anesth (2009) 0.82
Ipsilateral pedicle TRAM flaps for breast reconstruction: are they as safe as contralateral techniques? J Plast Reconstr Aesthet Surg (2008) 0.81
Impact of gender on mortality following primary angioplasty for acute myocardial infarction. Prog Cardiovasc Dis (2004) 0.81
The running shoe prescription: fit for performance. Phys Sportsmed (2005) 0.81
MAP1a associated light chain 3 increases microtubule stability by suppressing microtubule dynamics. Mol Cell Neurosci (2009) 0.80
Thrombus formation after successful stapler exclusion of the left atrial appendage. J Am Coll Cardiol (2010) 0.80
Synaptic plasticity and pain aversion. Eur J Pharmacol (2011) 0.80
Measuring outcomes of coronary artery bypass surgery: what is important and to whom? Arch Intern Med (2010) 0.80
Cutaneous furuncular myiasis: Human infestation by the botfly. Can J Plast Surg (2006) 0.80
Odontogenic sinus tract to the chin: a diagnostic dilemma. Cutis (2010) 0.80
Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. Am J Cardiol (2008) 0.79
Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State. Circ Cardiovasc Interv (2009) 0.79
Design of potent inhibitors of human beta-secretase. Part 2. Bioorg Med Chem Lett (2006) 0.79
Effect of patient navigation on enrollment in cardiac rehabilitation. JAMA Intern Med (2013) 0.79
Repeated bilateral reduction mammaplasty: a 12-year experience. Plast Reconstr Surg (2010) 0.78
Excitability of skeletal muscle during development, denervation, and tissue culture. Tissue Eng (2007) 0.78
Cytoskeletal interactions of synapsin I in non-neuronal cells. Biochem Biophys Res Commun (2004) 0.78